Healthcare at Home

In 1992, Charles Walsh started Healthcare at Home with a focused mission: to deliver specialized medications and clinical care directly to patients' homes. The company began by supplying a range of complex medications, creating patient support programs for those with chronic illnesses, cancer, and rare diseases. This model aimed to move treatment out of the traditional hospital setting, offering a new level of convenience and comfort for patients across the UK. The company established itself as a key partner for Britain's National Health Service, working with every NHS trust. Its core business was providing complex healthcare services within the home environment. This focus attracted investors, and in 2012, a significant event reshaped its future: the private equity firm Vitruvian Partners acquired Healthcare at Home. This move provided new backing and set the stage for the company's next phase of growth. In July 2021, the company took a major step in its evolution by rebranding to Sciensus. This change reflected a broader, more forward-thinking approach, harnessing digital technology and patient insight. Today, Sciensus continues its work as a global life sciences business, supporting hundreds of thousands of patients annually.